ArticleFrontiers in surgery2026
Regenerative peripheral nerve interface following forequarter amputation: a case report.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Forequarter amputation is a radical surgical procedure for malignant bone and soft tissue tumors involving the shoulder girdle, typically indicated for cases where limb salvage is not feasible due to extensive local invasion. However, post-amputation neuroma and phantom limb pain are major complications, occurring in 80%-90% of cases and severely impairing patients' quality of life. Traditional nerve management techniques often fail to prevent recurrent neuroma formation. The Regenerative Peripheral Nerve Interface (RPNI) is an emerging technique designed to guide axonal regeneration and mitigate pain. However, its application in oncologic high-level amputations has not been widely reported. Methods: We report the case of a 68-year-old female who underwent forequarter amputation for a malignant tumor of the left upper arm with simultaneous prophylactic RPNI reconstruction. The main trunks of the brachial plexus were sharply transected, and their stumps were implanted into small segments of denervated free muscle graftsharvested from the brachioradialis muscle of the amputated limb to promote organized axonal regeneration. Results: The patient's postoperative course was uneventful, without infection or other complications. Follow-ups at 1, 3, 6, and 12 months demonstrated significant and sustained relief of residual limb pain. The Visual Analog Scale (VAS) score decreased from a preoperative level of 9 to 0 Crucially, the patient reported no phantom limb pain or symptomatic neuroma-related discomfort during follow-up. Final pathology confirmed osteosarcoma. Conclusion: Concurrent RPNI reconstruction during forequarter amputation for malignancy is a safe and effective strategy to prevent postoperative neuropathic pain. This innovative application in high-level amputation patients offers a promising approach to improving quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.